These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 17389009

  • 1. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB, Bajzar L.
    J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
    [Abstract] [Full Text] [Related]

  • 2. The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instability.
    Walker JB, Bajzar L.
    J Biol Chem; 2004 Jul 02; 279(27):27896-904. PubMed ID: 15128744
    [Abstract] [Full Text] [Related]

  • 3. A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.
    Schneider M, Nesheim M.
    J Biol Chem; 2004 Apr 02; 279(14):13333-9. PubMed ID: 14715655
    [Abstract] [Full Text] [Related]

  • 4. TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots.
    Mutch NJ, Thomas L, Moore NR, Lisiak KM, Booth NA.
    J Thromb Haemost; 2007 Apr 02; 5(4):812-7. PubMed ID: 17388801
    [Abstract] [Full Text] [Related]

  • 5. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
    Morishima Y, Honda Y.
    J Thromb Thrombolysis; 2019 Jul 02; 48(1):103-110. PubMed ID: 30972711
    [Abstract] [Full Text] [Related]

  • 6. Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin.
    Kovács A, Szabó L, Longstaff C, Tenekedjiev K, Machovich R, Kolev K.
    Thromb Res; 2014 Jan 02; 133(1):80-7. PubMed ID: 24094605
    [Abstract] [Full Text] [Related]

  • 7. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH, Rijken DC.
    Thromb Haemost; 2004 Mar 02; 91(3):473-9. PubMed ID: 14983222
    [Abstract] [Full Text] [Related]

  • 8. Increased urokinase and consumption of α2 -antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay.
    Longstaff C, Locke M.
    J Thromb Haemost; 2019 Jan 02; 17(1):195-205. PubMed ID: 30451372
    [Abstract] [Full Text] [Related]

  • 9. Elucidating the molecular mechanisms of fibrinolytic shutdown after severe injury: The role of thrombin-activatable fibrinolysis inhibitor.
    Coleman JR, Moore EE, Kelher MR, Jones K, Cohen MJ, Banerjee A, Silliman CC.
    J Trauma Acute Care Surg; 2023 Jun 01; 94(6):857-862. PubMed ID: 36787438
    [Abstract] [Full Text] [Related]

  • 10. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM, Kalnoski MH, Frederick M, Chandler WL.
    Thromb Res; 2005 Jun 01; 115(4):327-40. PubMed ID: 15668193
    [Abstract] [Full Text] [Related]

  • 11. Combined effect of a direct oral anticoagulant edoxaban and an inhibitor of activated thrombin-activatable fibrinolysis inhibitor on clot lysis.
    Morishima Y, Kamisato C, Honda Y.
    J Thromb Thrombolysis; 2020 Jan 01; 49(1):94-99. PubMed ID: 31396790
    [Abstract] [Full Text] [Related]

  • 12. Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.
    Weitz JI, Leslie B, Hirsh J, Klement P.
    J Clin Invest; 1993 Apr 01; 91(4):1343-50. PubMed ID: 7682569
    [Abstract] [Full Text] [Related]

  • 13. An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
    Nagashima M, Werner M, Wang M, Zhao L, Light DR, Pagila R, Morser J, Verhallen P.
    Thromb Res; 2000 May 15; 98(4):333-42. PubMed ID: 10822080
    [Abstract] [Full Text] [Related]

  • 14. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
    Leebeek FW, Kluft C, Knot EA, de Maat MP, Wilson JH.
    Gastroenterology; 1991 Nov 15; 101(5):1382-90. PubMed ID: 1718809
    [Abstract] [Full Text] [Related]

  • 15. Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin.
    Schneider M, Brufatto N, Neill E, Nesheim M.
    J Biol Chem; 2004 Apr 02; 279(14):13340-5. PubMed ID: 14715654
    [Abstract] [Full Text] [Related]

  • 16. Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis.
    Incampo F, Carrieri C, Galasso R, Scaraggi FA, Di Serio F, Woodhams B, Semeraro N, Colucci M.
    J Thromb Haemost; 2013 Feb 02; 11(2):315-24. PubMed ID: 23256818
    [Abstract] [Full Text] [Related]

  • 17. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
    de Haan J, van Oeveren W.
    Thromb Res; 1998 Nov 15; 92(4):171-9. PubMed ID: 9840026
    [Abstract] [Full Text] [Related]

  • 18. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
    Mastroroberto P, Chello M, Zofrea S, Marchese AR.
    Eur J Cardiothorac Surg; 1995 Nov 15; 9(3):143-5. PubMed ID: 7540397
    [Abstract] [Full Text] [Related]

  • 19. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T, Gando S, Morimoto Y, Mashio H, Goda Y, Kawahigashi H, Kemmotsu O.
    Thromb Res; 2001 Dec 01; 104(5):301-7. PubMed ID: 11738071
    [Abstract] [Full Text] [Related]

  • 20. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
    Aoki N, Moroi M, Tachiya K.
    Thromb Haemost; 1978 Feb 28; 39(1):22-31. PubMed ID: 77050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.